Octreotide acetate 10mg, 20mg, 30mg; susp for IM inj after dilution; contains mannitol. Give by intragluteal IM inj. Not currently receiving octreotide: initiate therapy with immediate-release ...

When Signifor LAR was approved in 2014, Novartis was suggesting it could become a replacement for its blockbuster Sandostatin LAR (octreotide acetate) depot product, which was making annual sales ...